Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Deissler

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Therapeutic transfer of DNA encoding adenoviral E1AHelmut Deissler, Bertram Opalka
Current Opinion in Obstetrics & Gynecology|January 25, 2003
Angiogenesis: prognostic and therapeutic implications in gynecologic and breast malignanciesGeorg Sauer, Helmut Deissler
Current Cancer Drug Targets|May 23, 2006
Molecular targets of ovarian carcinomas with acquired resistance to platinum/taxane chemotherapyChristian Kurzeder, Georg Sauer, Helmut Deissler
Biomedical Reports|October 11, 2021
pH-dependent vs. constant release of mesalazine in the treatment of ulcerative colitis: Do drug delivery concepts determine therapeutic efficacy? (Review)Helmut Deissler, Heinrich Krammer, Anton Gillessen
Protein and Peptide Letters|June 11, 2009
Glycosylation of tetraspanin Tspan-1 at four distinct sites promotes its transition through the endoplasmic reticulumClaus-Jürgen Scholz, Georg Sauer, Helmut Deissler
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 19, 2002
New molecular targets of breast cancer therapyGeorg Sauer, Helmut Deissler, Christian Kurzeder, et al.
The British Journal of Ophthalmology|January 29, 2011
Inhibition of vascular endothelial growth factor (VEGF) is sufficient to completely restore barrier malfunction induced by growth factors in microvascular retinal endothelial cellsHeidrun L Deissler, Helmut Deissler, Gabriele E Lang
Investigative Ophthalmology & Visual Science|August 1, 2009
Inhibition of protein kinase C is not sufficient to prevent or reverse effects of VEGF165 on claudin-1 and permeability in microvascular retinal endothelial cellsHeidrun L Deissler, Helmut Deissler, Gabriele E Lang
The British Journal of Ophthalmology|April 28, 2012
Actions of bevacizumab and ranibizumab on microvascular retinal endothelial cells: similarities and differencesHeidrun L Deissler, Helmut Deissler, Gabriele E Lang
Biophysical Journal|July 26, 2005
Measuring single-bond rupture forces using high electric fields in microfluidic channels and DNA oligomers as force tagsStefanie Breisch, Julian Gonska, Helmut Deissler, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Therapeutic transfer of DNA encoding adenoviral E1AHelmut Deissler, Bertram Opalka
Current Opinion in Obstetrics & Gynecology|January 25, 2003
Angiogenesis: prognostic and therapeutic implications in gynecologic and breast malignanciesGeorg Sauer, Helmut Deissler
Current Cancer Drug Targets|May 23, 2006
Molecular targets of ovarian carcinomas with acquired resistance to platinum/taxane chemotherapyChristian Kurzeder, Georg Sauer, Helmut Deissler
Biomedical Reports|October 11, 2021
pH-dependent vs. constant release of mesalazine in the treatment of ulcerative colitis: Do drug delivery concepts determine therapeutic efficacy? (Review)Helmut Deissler, Heinrich Krammer, Anton Gillessen
Protein and Peptide Letters|June 11, 2009
Glycosylation of tetraspanin Tspan-1 at four distinct sites promotes its transition through the endoplasmic reticulumClaus-Jürgen Scholz, Georg Sauer, Helmut Deissler
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 19, 2002
New molecular targets of breast cancer therapyGeorg Sauer, Helmut Deissler, Christian Kurzeder, et al.
The British Journal of Ophthalmology|January 29, 2011
Inhibition of vascular endothelial growth factor (VEGF) is sufficient to completely restore barrier malfunction induced by growth factors in microvascular retinal endothelial cellsHeidrun L Deissler, Helmut Deissler, Gabriele E Lang
Investigative Ophthalmology & Visual Science|August 1, 2009
Inhibition of protein kinase C is not sufficient to prevent or reverse effects of VEGF165 on claudin-1 and permeability in microvascular retinal endothelial cellsHeidrun L Deissler, Helmut Deissler, Gabriele E Lang
The British Journal of Ophthalmology|April 28, 2012
Actions of bevacizumab and ranibizumab on microvascular retinal endothelial cells: similarities and differencesHeidrun L Deissler, Helmut Deissler, Gabriele E Lang
Biophysical Journal|July 26, 2005
Measuring single-bond rupture forces using high electric fields in microfluidic channels and DNA oligomers as force tagsStefanie Breisch, Julian Gonska, Helmut Deissler, et al.
Pageof 7